Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Lipika Goyal

Director of Gastrointestinal Oncology

Stanford University

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States

Articles (11)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (4)

Shunsuke Kondo

Professor

Tokyo Women's Medical University

JAPAN

View details

John Bridgewater

UCL Cancer Institute

UNITED KINGDOM

View details

James Harding

Memorial Sloan Kettering Cancer Center

UNITED STATES

View details

Camila Braganca Xavier

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lipika Goyal

Research Interests

Make your next move.

Explore related searches

Articles (11)

Personalized Therapy in Advanced Cholangiocarcinoma: Contemporary Treatment Approaches and Future Directions

Precision oncology needs precision trial design: lessons from FGFR2-rearranged cholangiocarcinoma

Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer trials

Final Results from a First-in-Human Phase 1 Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations

Genomic correlates of response and resistance to the irreversible FGFR1-4 inhibitor futibatinib based on biopsy and circulating tumor DNA profiling

Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1–4 Inhibitor: Pooled Safety Analysis of 469 Patients

Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial

Dual checkpoint inhibition in gallbladder cancer: Bridging new hope with the need for biomarkers

Are FGFR Fusions and Mutations the Next Tumor-Agnostic Targets in Oncology?

Precision Medicine and Immunotherapy Have Arrived for Cholangiocarcinoma: An Overview of Recent Approvals and Ongoing Clinical Trials

Mudras in Medicine: A Role for Dance in Appreciating Nonverbal Communication in the Clinical Encounter

Collaborators (4)

Shunsuke Kondo

John Bridgewater

James Harding

Camila Braganca Xavier

Make your next move.